Literature DB >> 28019725

The KCC3 cotransporter as a therapeutic target for peripheral neuropathy.

Eric Delpire1, Kristopher T Kahle2.   

Abstract

Entities:  

Keywords:  Bumetanide; KCC2; KCC3; KCl cotransporter; NKCC1; Na-K-2Cl cotransporter; SPAK/OSR1; WNK; cell swelling; cell volume regulation; furosemide

Mesh：

Substances：

Year:  2017        PMID： 28019725     DOI： 10.1080/14728222.2017.1275569

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN： 1472-8222            Impact factor:   6.902


× No keyword cloud information.
  5 in total

1.  Structure of the human cation-chloride cotransport KCC1 in an outward-open state.

Authors:  Yongxiang Zhao; Jiemin Shen; Qinzhe Wang; Manuel Jose Ruiz Munevar; Pietro Vidossich; Marco De Vivo; Ming Zhou; Erhu Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-27       Impact factor: 12.779

2.  KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria.

Authors:  Elinor Hortle; Lora Starrs; Fiona C Brown; Stephen M Jane; David J Curtis; Brendan J McMorran; Simon J Foote; Gaetan Burgio
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

Review 3.  The WNK-SPAK/OSR1 Kinases and the Cation-Chloride Cotransporters as Therapeutic Targets for Neurological Diseases.

Authors:  Huachen Huang; Shanshan Song; Suneel Banerjee; Tong Jiang; Jinwei Zhang; Kristopher T Kahle; Dandan Sun; Zhongling Zhang
Journal:  Aging Dis       Date:  2019-06-01       Impact factor: 6.745

Review 4.  A role for KCC3 in maintaining cell volume of peripheral nerve fibers.

Authors:  Bianca Flores; Cara C Schornak; Eric Delpire
Journal:  Neurochem Int       Date:  2018-01-31       Impact factor: 4.297

Review 5.  Targeting the WNK-SPAK/OSR1 Pathway and Cation-Chloride Cotransporters for the Therapy of Stroke.

Authors:  Sunday Solomon Josiah; Nur Farah Meor Azlan; Jinwei Zhang
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.